September, 2016
Partager Partager Partager Partager

We are thrilled to be back with a myriad of “rentrée” news – from the Genopole Young Biotech Award selection underway to a new partnership and expansion for some of our companies, an international symposium in December, a mission to Sweden, and so much more!

Genopole Young biotech Award

Genopole Young Biotech Award – Get into Action

The 2016 edition of the Genopole Young Biotech Award is underway. Your start-up starts here!
Are you looking to give life to or accelerate the development of your innovation? Then the Genopole Competition is for you.

You have the idea, we have the means.

The Genopole biocluster is the ideal site to develop your innovation, an ecosystem unique in France combining research, business and technology. The Genopole Competition is your opportunity to join a cluster created specifically for the development of biotechnologies and to benefit from personalized accompaniment.
Learn more about its conditions, calendar and prizes.

Download the candidate dossier. {...} read more

A New Partnership between Global & Cristal Union

IBN-One, a subsidiary of Global Bioenergies and Cristal Union, today announced it has awarded the first engineering contract for its bio-isobutene plant to Technip and IPSB.

Following a consultation process by IBN-One in spring 2016, the initial engineering work contract has been awarded to a consortium that includes Technip, a global leader in engineering for the energy, petrochemical and chemical industries, and IPSB, an engineering firm specializing in sugar and biotechnologies.

This first front-end engineering design (FEED) phase will run for 12 months and precedes the detailed engineering studies for the plant's construction.
Bernard Chaud, Chairman and CEO of IBN-One and Director of Industrial Strategy of Global Bioenergies said: “IBN-One is the project owner of the first plant to use Global Bioenergies’ isobutene technology. During this phase, engineers will specify the design of the equipment and the connections between the plant’s different subunits, as well as its integration at a Cristal Union sugar beet site. Leaders in their respective fields, Technip and IPSB provide two key and complementary areas of expertise to advance the project.”

The contracts for the second phase, comprising the detailed engineering studies, will be awarded at a later date. Construction is then expected to commence early in 2018.
Read more {...} read more
Synthetic biology 2016/12/06

December 6, 2016

Synthetic biology stands among the major scientific advancements of the last decade and offers a wide range of industrial applications and new production techniques. With this in mind, Genopole - in partnership with TWB and IAR - is organizing a colloquium entitled "Synthetic Biology: from Ideas to Market" to explore this promising sector.
This international colloquium will be held on 6 December at the University Paris Descartes. With its focus on the journey of synthetic biology from research to the business world and the transfer of lab technologies toward industrial development and the bioeconomy, the colloquium is intended for industrials, start-ups, academics, investors and other stakeholders eager to explore synthetic biology's potential for industrial deployment.

There is still time to register! {...} read more


Genopole is pleased to welcome two new companies on its campus: InnovaFeed and Enalees.

InnovaFeed, which produces insect proteins to feed farmed fish and build a sustainable future for the world's food supply, will be developing its first research laboratories in France at Genopole.
InnovaFeed Logo
Enalees Logo Enalees is specialized in animal health and has installed its company at Genopole to develop a new kind of diagnostic test. It has just set up in its brand new offices and R&D lab stretching over more than 200 sq.m.

We wish these 2 companies much success in their future endeavors.

Nordic Life Science Days – Genopole in Sweden

Early on in the month, a Genopole delegation, along with Business France, went on a 2-day mission to Sweden organized by Medicen (life science organization from the Paris Region) followed by the Nordic Life Science Days conference in Stockholm.

Read more about the mission {...} read more
Laurent PEPIN at NLSDAYS 2016

Rendez-vous CARNOT 2016

Come Meet Us At "The Rendez-vous Carnot"

Genopole will be present at the Rendez-vous Carnot meeting in Lyon from 4th to 5th October.
Be sure to meet up with Laurent Pépin at our Genopole stand.

Read more {...} read more

KBio – A Fruitful Collaboration

As part of the Strategic Exploratory Agreement (SEA) signed in June 2016 with the KBIO research cluster (Osong Medical Innovation Foundation), Genopole hosted Korean delegates early September to initiate the exchanges on potential collaborative programs between France and Korea.

Themes that will be covered by Genopole and KBIO in the forthcoming meetings of the SEA Steering Committee over the next quarter include the strategy of biocluster development, training and nurturing of entrepreneurs, partnership in drug discovery (specifically gene and cell therapy), implementation of clinical protocols in personalized medicine, reciprocal soft landing of French and Korean biotech companies, as well as financing of cross-national initiatives.
KBio Logo
A number of companies and French government officials will also be meeting with Korean counterparts at the France-Korea Forum on Industrial Innovation which is taking place in Seoul on October 26, 2016.
Glowee Logo
October 1st, "La nuit blanche"

Come check out how the sea can light up "la nuit blanche" on October 1st with a unique installation made by Glowee.
AFM-Téléthon Logo
30th Edition of the Téléthon

The 30th edition of the Téléthon, the French fundraising event towards research on neuromuscular diseases, will take place on December 2nd and 3rd. Watch this space for more information on the events and this year's sponsor!

Key figures 2015
Genopole 2015 Key Figures

Genopole hosts 82 biotech companies that raised 100 M€ in 2015, bringing the total of funds raised over the last 15 years to a new record level at over 500 M€.
Read the Annual Report {...} read more
  For additional information, write to